Conducting a digital study during a pandemic

Changing the dynamics of clinical trials

According to Frost & Sullivan, more than $25 billion is spent annually on clinical trials in the United States. But what happens when a global pandemic disrupts traditional clinical studies?

As in-person health care visits dramatically declined in 2020, the Optum Digital Research Network (DRN) leveraged real-world data to conduct a digital clinical trial of patients with diabetes.

Presented during the virtual AMGA 2021 Annual Conference, this video shows how Optum leveraged electronic health record data and patient-finding processes for its study.

A panel of health care experts who collaborated on the project share their insights on its processes and key findings. They also discuss how Optum solutions streamline traditional clinical trial processes, making it easier to recruit and engage patients and health care providers for future studies.